Pulmatrix
PULM
8 hedge funds and large institutions have $22.3M invested in Pulmatrix in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
11% less funds holding
Funds holding: 9 → 8 (-1)
13% less capital invested
Capital invested by funds: $25.7M → $22.3M (-$3.38M)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$298K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$91.3K |
| 3 |
SIM
Spark Investment Management
New York
|
+$84.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$92K |
| 2 |
Morgan Stanley
New York
|
-$15.4K |
| 3 |
BJ
BlackRock Japan
Tokyo,
Japan
|
-$7K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$4K |
PULM Hedge Fund Activity: Q4 2015 in Review
8 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Pulmatrix (PULM) for Q4 2015, worth a combined $22.3M — down 13% from $25.7M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PULM and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Glenmede Trust, opening a new position worth an estimated $298K. The largest seller was Goldman Sachs, exiting entirely with an estimated $92K sold.
- 8 institutional investors held Pulmatrix (PULM) as of Q4 2015, down from 9 in Q3 2015.
- Funds reported $22.3M of Pulmatrix stock for Q4 2015, down 13% quarter-over-quarter.
- 3 funds opened new Pulmatrix positions in Q4 2015 and 4 closed out, a net change of -1 holder.
- The largest Pulmatrix buyer in Q4 2015 was Glenmede Trust, an estimated $298K added.
- The largest Pulmatrix seller in Q4 2015 was Goldman Sachs, an estimated $92K sold.
Based on aggregated 13F filings for Q4 2015.